PSH0.XETRA Sernova Biotherapeutics Inc

Healthcare Biotechnology XETRA Stock Exchange
0.0710 EUR
Close of Nov 6, 2026
0.0486 0.1990
Market cap
EUR 26.8M
P/E
7.1x
P/B
16.36x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2026.

Is PSH0.XETRA undervalued?

Graham number
Price0.0710
Graham value0.0312
Premium127.2%

PSH0.XETRA trades 127.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sernova Biotherapeutics Inc fundamental analysis

No fundamental analysis for Sernova Biotherapeutics Inc yet.

Sernova Biotherapeutics Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sernova Biotherapeutics Inc

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Ser…

Full company profile